Media Centre

Home About Us Services Forsøgspersoner Media Centre Contact

> News

> Events

> Downloads

> Links

Seperator

News

Enrolment completed in study of new COVID-19 treatment

DanTrials has recently sucessfully completed the enrolment of 64 healthy subjects in a study investigating the safety of a new treatment against COVID-19.

Send an email to info@dantrials.com or give CEO Torben Balchen a call on (+45) 3135 2683 to learn more.


Results of prostate cancer study published

The results of a first-time-into-humans study conducted at DanTrials where prostate cancer patients were vaccinated against RhoC have recently been published in Journal for ImmunoTherapy of Cancer: Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial

Send an email to info@dantrials.com or give CEO Torben Balchen a call on (+45) 3135 2683 to learn more.


> To top of page

Seperator

Events

There are no events at the moment.

> To top of page

Seperator

Downloads

None available at the moment.

> To top of page

Seperator

Links

The Danish Medicines Agency

The National Committee on Health Research Ethics

The Danish Data Protection Agency

> To top of page

Vortexing af blodprøve